CCL26 and neoplasm: No studies to date have investigated the role of eotaxin-3 in esophageal cancer, however in colon cancer, eotaxin-3 induced tumor associated macrophages by binding to the CCR3 receptor and enhancing the invasiveness of tumor cells (62).